CUPERTINO, CA / ACCESSWIRE / May 9, 2019 / Aemetis, Inc. (NASDAQ:AMTX), an advanced renewable fuels and biochemicals company, today announced its financial results for the three months ended March 31, 2019.
Aemetis' first quarter of 2019 included significant announcements such as the entry into the biomethane business with a project in the Central Valley of California, expansion of the India plant pretreatment capacity to 50 million gallons, and the opening of a new customer base in India. Aemetis also announced the completion of several significant funding milestones for its ultra-low carbon California cellulosic ethanol biorefinery, which is expected to add approximately $80 million of high margin revenues. Utilizing thousands of tons of waste wood from California's Central Valley, the Aemetis cellulosic ethanol biorefinery is expected to produce the state's lowest carbon ethanol fuel, reducing greenhouse gas emissions in the process.
Key milestones during Q1 2019 included:
Today, Aemetis will host an earnings review call at 11:00 am Pacific (PT). For details on the call, visit: http://www.aemetis.com/investors/conference-calls/.
Financial Results for the Three Months Ended March 31, 2019
Revenues during the first quarter of 2019 were $41.9 million, compared to $43.0 million for the first quarter of 2018. North America increased the volume of ethanol sold from 16.1 million gallons to 16.2 million gallons, which was offset by a softening price from $1.76 per gallon to $1.68 per gallon, while India's biodiesel price was $851 per metric ton compared to $839 per metric ton with tons sold at 5,286 tons compared to 5,182 tons.
Gross profit for the first quarter of 2019 decreased by $2.2 million to a $0.4 million loss, compared to gross profit of $1.9 million during the first quarter of 2018.
Selling, general and administrative expenses were $4.2 million during the first quarter of 2019, compared to $3.8 million in the first quarter of 2018, primarily driven by an increase in professional fees.
Operating loss was $4.6 million for the first quarter of 2019, compared to operating loss of $2.0 million for the same period in 2018.
Interest expense, excluding accretion of Series A preferred units in the Aemetis Biogas LLC subsidiary, decreased to $6.2 million during the first quarter of 2019 compared to $9.0 million during the first quarter of 2018. Included in interest expense during the first quarter of 2018 was a one-time loan fee charge of $3.6 million. Additionally, our Aemetis Biogas initiative recognized $449 thousand of accretion of the preference payments on its preferred stock.
Net loss decreased to $10.7 million for the first quarter of 2019, compared to net loss of $11.1 million for the first quarter of 2018.
Cash at the end of the first quarter of 2019 was $43 thousand compared to $1.2 million at the close of the fourth quarter of 2018.
About Aemetis
NON-GAAP FINANCIAL INFORMATION
Safe Harbor Statement
CONTACT:
External Investor Relations Contact:
Kirin Smith
PCG Advisory Group
(646) 863-6519
[email protected]
Company Investor Relations/
Media Contact:
Todd Waltz
(408) 213-0940
[email protected]
AEMETIS, INC.
<_align3d_22_center22_> CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
<_align3d_22_center22_> (unaudited, in thousands except per share data) </_align3d_22_center22_></_align3d_22_center22_>
AEMETIS, INC.
<_align3d_22_center22_> CONSOLIDATED CONDENSED BALANCE SHEETS
<_align3d_22_center22_> (unaudited, in thousands) </_align3d_22_center22_></_align3d_22_center22_>
RECONCILIATION OF ADJUSTED EBITDA TO NET INCOME/(LOSS)
<_align3d_22_center22_> (unaudited, in thousands)
<_align3d_22_center22_> </_align3d_22_center22_></_align3d_22_center22_>
PRODUCTION AND PRICE PERFORMANCE
<_align3d_22_center22_> (unaudited) </_align3d_22_center22_>
SOURCE: Aemetis, Inc.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
